Name: Dr. Stanley Crittenden
Previous title: Enterprise chief medical officer, Quantum Health
New title: Chief medical officer, Cigna Healthcare
Crittenden took on the role as chief medical officer of Cigna’s health benefits division, effective Monday, the insurer said.
He replaces Dr. Amy Flaster, who late last year was promoted to serve as CMO of the entire Cigna business, including the company’s insurance offerings and health services unit Evernorth.
Crittenden will oversee the implementation of Cigna Healthcare’s clinical programs, the firm said in a press release issued Monday. He joins Cigna from care navigation company Quantum Health, where he led clinical strategy and programs.
Crittenden also previously served as CMO of value-based kidney care organization Evergreen Nephrology, and held medical director roles at insurers Anthem and Humana, according to his LinkedIn.
“His background in advancing healthcare innovation and building high‑performing clinical teams will help drive our clinical strategy to deliver personalized, high‑quality, and affordable care—along with an exceptional experience for both customers and clinicians,” Flaster said in a statement.
Crittenden’s appointment comes after Cigna has changed up its leadership team over the past year. Last month, the company said Brian Evanko, currently the company’s chief operating officer, will become CEO when chief executive David Cordani retires in July.
Evanko took on the COO role about a year ago as part of a C-suite restructuring that also elevated Ann Dennison as CFO across the enterprise.
Meanwhile, health insurers are facing a more challenging financial environment as increased medical spending threatens their bottom lines. In February, Cigna laid off around 2,000 workers in a bid to cut costs.
Still, the company’s fourth-quarter financial results outperformed analysts’ expectations, with adjusted revenue increasing 10% and adjusted operational income rising 16% over the prior year period.
Cigna Healthcare’s revenue declined because it sold its Medicare Advantage business last year, but operational income rose after it increased premiums for its stop-loss insurance offerings.
The company will report first-quarter earnings at the end of April.
